Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.72    0.48 (1.40%)
Bid:
34.80
Ask:
35.52
Spread: 0.72 (2.069%)
Market Cap: £555.18m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

SBTi approval for carbon reduction targets

1 Apr 2022 09:30

RNS Number : 9206G
Hays PLC
01 April 2022
 

Hays plc: Approval of Science-Based Targets

 

Hays plc is pleased to announce that its Science-Based Targets (SBT) have been approved by the Science-Based Targets initiative (SBTi). These targets are a key part of its ambition to be the first global specialist recruitment firm to reach Net Zero. This landmark step demonstrates Hays' firm commitment to fighting climate change, and its targets have been validated by SBTi as being consistent with GHG reductions which will limit warming to 1.5˚C, the most ambitious goal of the Paris Agreement.

 

Hays has set two overarching targets for carbon reduction, now formally validated by the Science Based Targets Initiative.

 

For its base year, which ended in March 2020 (i.e. pre-pandemic):

 

1. Reduce operational consumption: Hays commits to reduce absolute scope 1 and 2 GHG emissions by 50% by FY2026;

2. Reduce GHG emissions in the supply chain: Hays commits to reduce absolute scope 3 GHG emissions from purchased goods and services and capital goods by 50% by FY2030. Further, Hays also commits to reduce absolute scope 3 GHG emissions from business travel by 40% by FY2026.

 

To deliver these targets, Hays has put in place policies including moving offices to 100% renewable energy and targeting significant cuts to energy use, reducing business travel including a 40% reduction in flights by 2026, transitioning our fleet to electric and hybrid vehicles and working with companies in our supply chain which are committed to their own Net Zero journey's.

 

CEO Alistair Cox commented:

 

"Hays was proud to become a Carbon Neutral business in 2021, however we have always viewed this as a stepping stone on our path to becoming Net Zero. Net Zero requirements are far more stringent, requiring organisations to achieve emissions reductions consistent with limiting warming to 1.5°C and be wholly transparent in reporting their progress. Our actions to reduce Scope 1, 2 and 3 GHG emissions should result in a cumulative reduction in CO2 of c.65,000 tonnes over the next five years. Our ambition is to become the first global specialist recruiter to achieve Net Zero and take an active role in combatting climate change and promoting sustainability in all our operations".

 

 

LEI code: 213800QC8AWD4BO8TH08

 

 

Enquiries

 

Hays plc

 

David Phillips Head of Investor Relations & ESG + 44 (0) 333 010 7122

 

Finsbury

 

Guy Lamming / Anjali Unnikrishnan hays@finsbury.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRIBMFTMTAMMIT
Date   Source Headline
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM
3rd Oct 202511:09 amRNSDirector/PDMR Shareholding
1st Oct 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.